Clinical Trials

Sarah works alongside Dr. Sandhya Prashad to support patients pursuing interventional treatments for mood and anxiety disorders. Since joining the practice in 2023, she have served as the first point of contact for new patients, gathering medical and psychological histories to help assess clinical needs and eligibility for both treatment and research.

She has coordinated two PCORI-funded clinical trials with Yale University: Equivalence, a randomized non-inferiority trial comparing Racemic Ketamine and Esketamine, and Observe, a follow-up outcomes study. In addition, she has coordinated a National Institute of Mental Health funded trial with Baylor College of Medicine and The University of Pittsburgh on enhancing the durability of ketamine’s antidepressant effects. Her responsibilities span patient recruitment, data collection, regulatory compliance, and sponsor communications, ensuring adherence to GCP, FDA, and IRB standards.

Her background includes roles as a psychiatric patient coordinator in Chicago and as a Registered Behavior Technician in Houston, supporting children with Autism Spectrum Disorder. She holds an Associate in Arts degree from the College of DuPage and RBT certification through the Behavior Analyst Certification Board.

With a strong passion for interventional psychiatry, Sarah is particularly interested in how clinical care and research can work together to advance outcomes for patients with treatment-resistant conditions.